Connection

NATHAN FOWLER to Immunotherapy

This is a "connection" page, showing publications NATHAN FOWLER has written about Immunotherapy.
Connection Strength

1.002
  1. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021 06 14; 39(6):845-865.e7.
    View in: PubMed
    Score: 0.289
  2. Toxicity Management: Development of a Novel and Immune-Mediated Adverse Events Algorithm?. Clin J Oncol Nurs. 2017 04 01; 21(2 Suppl):53-59.
    View in: PubMed
    Score: 0.217
  3. Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. Neuro Oncol. 2016 Apr; 18(4):575-81.
    View in: PubMed
    Score: 0.196
  4. Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer. Cancer Cell. 2024 May 13; 42(5):759-779.e12.
    View in: PubMed
    Score: 0.089
  5. Unmet needs in the first-line treatment of follicular lymphoma. Ann Oncol. 2017 Sep 01; 28(9):2094-2106.
    View in: PubMed
    Score: 0.056
  6. Role of the tumor microenvironment in mature B-cell lymphoid malignancies. Haematologica. 2016 05; 101(5):531-40.
    View in: PubMed
    Score: 0.051
  7. Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma. Curr Opin Oncol. 2015 Sep; 27(5):384-91.
    View in: PubMed
    Score: 0.049
  8. Unmet needs in the treatment of mantle cell lymphoma. Clin Adv Hematol Oncol. 2013 Nov; 11(11 Suppl 18):1-19.
    View in: PubMed
    Score: 0.043
  9. The landscape of new drugs in lymphoma. Nat Rev Clin Oncol. 2017 Jun; 14(6):335-346.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.